Key facts
- EarSwitch’s last known valuation is $5.0M (May 2023).
- It has raised $3.4M; the latest was Angel (individual) in Apr 2026.
- Notable investors include Innovate UK, UK Research and Innovation, MNL Nominees, WCS Nominees, Nordic Mentor Network For Entrepreneurship — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for EarSwitch
- ·The full record, as it builds
Funding rounds
No funding rounds for EarSwitch are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About EarSwitch
Developer of in-ear biometric technology designed to assist neurologically impaired patients. The company's technology uses switches and sensors to detect movements of the tensor tympani muscle and operate assistive devices such as a mouse, keyboard, and mobile phone, enabling neurologically impaired people to control devices.
- Sector
- Healthcare
- HQ
- Manchester, United Kingdom
- Founded
- 2019
- Employees
- 14
- Website
- earswitch.co.uk/
- Ownership
- Privately Held (backing)
EarSwitch doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in EarSwitch shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on EarSwitch in its N-PORT filings yet. We sweep new filings monthly.